1. Home
  2. MLKN vs CRVS Comparison

MLKN vs CRVS Comparison

Compare MLKN & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MillerKnoll Inc.

MLKN

MillerKnoll Inc.

HOLD

Current Price

$17.35

Market Cap

1.0B

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$18.15

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLKN
CRVS
Founded
1905
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
MLKN
CRVS
Price
$17.35
$18.15
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$30.17
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
03-25-2026
05-07-2026
Dividend Yield
4.31%
N/A
EPS Growth
N/A
48.04
EPS
0.98
N/A
Revenue
$3,669,900,000.00
N/A
Revenue This Year
$5.94
N/A
Revenue Next Year
$3.78
N/A
P/E Ratio
$17.77
N/A
Revenue Growth
1.14
N/A
52 Week Low
$13.77
$3.17
52 Week High
$23.18
$26.95

Technical Indicators

Market Signals
Indicator
MLKN
CRVS
Relative Strength Index (RSI) 55.61 64.18
Support Level $16.55 $16.15
Resistance Level $17.77 $18.73
Average True Range (ATR) 0.60 1.02
MACD 0.45 0.39
Stochastic Oscillator 81.70 70.07

Price Performance

Historical Comparison
MLKN
CRVS

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: